Gaudium IVF IPO GMP, Price, Date, Allotment & Subscription Status

By REPAKA PAVAN ADITYA

|

Updated on: Feb 24th, 2026

|

9 min read

Gaudium IVF and Women's Health Limited is launching its Initial Public Offering (IPO), becoming the first fertility care company in India to go public. The issue comprises a fresh issue of shares along with an Offer for Sale (OFS) by existing shareholders. Here’s a quick look at its GMP, price band, key dates, subscription and financial performance.

The GMP of the Gaudium IVF IPO GMP is approx ₹8.5 as of today, 24 February 2026.

What is Gaudium IVF IPO?

The Gaudium IVF IPO is a book-built issue comprising a fresh issue and an Offer for Sale (OFS).

  • Issue Size: ₹165 crore
  • Listing Exchanges: BSE and NSE
  • Lead Manager: Sarthi Capital Advisors Private Limited
  • Registrar: Bigshare Services Private Limited

Gaudium IVF IPO Key Timeline

Event

Date

IPO Opening DateFebruary 20, 2026
IPO Closing DateFebruary 24, 2026
Basis of AllotmentFebruary 25, 2026
Initiation of RefundsFebruary 26, 2026
Credit of Shares to DematFebruary 26, 2026
IPO Listing DateFebruary 27, 2026

Gaudium IVF & Women Health Ltd Key IPO Details

  • IPO Open Date: February 20, 2026.
  • IPO Close Date: February 24, 2026.
  • Issue Size: ₹165 Crores (20,886,200 equity shares).
  • Fresh Issue: ₹90 Crores (11,392,500 equity shares).
  • Offer for Sale: ₹75 Crores (9,493,700 equity shares).
  • Face Value: ₹5 per equity share.
  • Price Band: ₹75 to ₹79 per share.
  • Lot Size: 189 shares.
  • Minimum Investment (Retail): ₹14,931 (at upper band).
  • Minimum Investment (sHNI): Approximately ₹208,034 (14 lots).
  • Minimum Investment (bHNI): Approximately ₹1,040,170 (70 lots).

IPO Reservation

  • Qualified Institutional Buyers (QIB): Not more than 50%.
  • Non-Institutional Investors (NII/HNI): Not less than 15%.
  • Retail Investors: Not less than 35%.
  • UPI Mandate Confirmation Cut-off: Tuesday, February 24, 2026, 5:00 PM.

Gaudium IVF IPO GMP Today

As of today February 24, 2026 the Gaudium IVF IPO GMP is approximately ₹8.5, implying a listing price of ₹87.5 per share, about 10.76% above the upper band of ₹79.

GMP Date

IPO Price

GMP

Expected Listing

Premium (%)

23-Feb-2026₹79₹8.5₹87.510.76%
23-Feb-2026₹79₹8.5₹87.510.76%
22-Feb-2026₹79₹8.5₹87.510.76%
21-Feb-2026₹79₹8.5₹87.510.76%
20-Feb-2026₹79₹8.5₹87.510.76%
19-Feb-2026₹79₹12₹9115.19%
18-Feb-2026₹79₹12₹9115.19%
17-Feb-2026₹79₹15₹9418.99%

Gaudium IVF IPO Subscription Status

Check the latest Gaudium IVF IPO subscription status today, including retail, QIB, and NII subscription details, in the table below. As the IPO opened today February 20, 2026, subscription stands at 040x across categories.

Type of Investor

Subscription (Multiples)

Qualified Institutional Buyers (QIB)0.00
Non-Institutional Investors (NII)0.36
Retail Investors0.66
Total0.40

Gaudium IVF IPO Objectives

  • Expansion and Growth: Funds raised via IPO will be for capital expenditure to establish 19 new IVF centres across India.
  • Debt Reduction: Repayment or pre-payment of certain outstanding borrowings (₹20 crore allocated).
  • General Corporate Purposes: Remaining funds for strategic initiatives, marketing, operational enhancements, and working capital.
  • No Proceeds from OFS: Proceeds from the OFS component go entirely to the selling shareholder (promoter, Dr Manika Khanna). The company receives funds only from the fresh issue portion.

About Gaudium IVF and Women Health Limited

Founded in 2015, Gaudium IVF and Women’s Health Limited has been at the forefront of fertility and women’s healthcare in India. The company offers IVF treatments, assisted reproductive technologies (ART), and a full range of women’s health services. 

Operating through a hub-and-spoke model, it runs multiple centres across the country and serves patients not just from India but also from abroad, including Canada, the UK, the US, and parts of Africa.

  • Headquarters: B1/51, Janak Puri, New Delhi – 110058, India
  • Ownership: Promoter-led by Dr Manika Khanna (pre-IPO stake: 99.32%, post-IPO: 70.73%).
  • Scale: Network of hubs and spokes; focus on advanced ART procedures, high-risk pregnancies, cryopreservation, and related care.

Gaudium IVF Business Overview

  • Core Business: Gaudium IVF is regarded as a pioneer in India’s fertility care space, offering specialised services such as IVF, ICSI, IUI, medical support for surrogacy, and comprehensive gynaecological care.
  • Scale: Its operations go beyond fertility treatments, with an in-house pharmacy, a nutraceuticals business through its subsidiary, and a growing focus on mother-and-child wellness services.
  • Market Position: The company holds a strong position in a rapidly expanding market, supported by rising awareness around infertility, increasing demand for assisted reproductive technologies (ART), and growth in medical tourism.
  • Expansion: Gaudium plans to expand aggressively by adding 19 new centres and diversifying into FMCG and maternal and healthcare products.

Gaudium IVF and Women Health Ltd Key Highlights

  • Pioneering Status: First fertility services company in India to go public, marking a historic milestone for the sector.
  • Strong Growth: Consistent increase in revenue and profitability over recent years, reflecting steady expansion and operational strength.
  • Strategic Importance: Its services play a key role in addressing rising infertility rates and improving access to specialised reproductive healthcare.
  • Professional Backing: Backed by an experienced founder and medical professional, the company maintains a strong patient-centric approach at the core of its operations.

Strengths and Challenges of Gaudium IVF and Women Health Ltd.

Strengths:

  • Gaudium IVF is a trusted leader in the IVF segment, which is known for advanced technology and strong success rates.
  • A hub-and-spoke setup enables them to reach more patients while maintaining consistent quality of care.

Challenges:

  • Relies heavily on skilled doctors and specialists, so keeping talent is key.
  • Must follow strict regulations such as the ART Act and the PNDT Act.
  • Faces competition in the fertility sector and needs to stay mindful of healthcare and ESG standards.

Gaudium IVF and Women Health Ltd Financial Performance

Here’s your financial data in a clean table format:

Period Ended

30 Sep 2025

31 Mar 2025

31 Mar 2024

31 Mar 2023

Assets (₹ Cr)106.6288.5151.0136.63
Total Income (₹ Cr)49.7570.9648.1544.26
PAT(₹ Cr)12.5119.1310.3213.53
EBITDA (₹ Cr)18.9528.6319.2720.07
Net Worth (₹ Cr)58.8546.3026.9922.73
Reserves & Surplus (₹ Cr)28.1615.6026.0021.74

How to Apply for Gaudium IVF IPO?

Investors who want to apply for this IPO can do so via ASBA (online/offline) or UPI.

How to Apply Online via ASBA/UPI:

  • Log in to your broker’s platform and go to the IPO section.
  • Choose Gaudium IVF and Women Health Ltd IPO.
  • Enter your bid details, including the number of lots and price.
  • Make the payment through ASBA (net banking) or UPI.
  • Submit the application and confirm the mandate before 5 PM on the IPO closing date.

Offline:

  • Obtain form from broker/exchange.
  • Fill in the details and submit to the broker.

Gaudium IVF and Women Health Limited IPO Allotment Status

The Gaudium IVF and Women Health Limited IPO allotment status will be available on Bigshare Services Private Limited on February 25, 2026. Follow these steps to check online:

  • Visit the Bigshare Services Private Limited website.
  • Select “Gaudium IVF and Women Health Limited” from the dropdown.
  • Choose PAN, application number, or DP/Client ID.
  • Enter details and search for status.

Note: Also check the NSE and BSE, or with your stockbroker, once the results are out on February 25, 2026.

Gaudium IVF and Women Health Ltd IPO Contact Details

Registrar:

  • Name: Bigshare Services Private Limited
  • Address: S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road, Andheri (East), Mumbai - 400093
  • Telephone: +91-22-6263 8200
  • E-mail: ipo@bigshareonline.com

Lead Manager:

  • Name: Sarthi Capital Advisors Private Limited
  • Contact Person: Deepak Pansare
  • Telephone: +91 22 4895 3624
  • Email: gaudium.ipo@sarthiwm.in

Company:

  • Name: GAUDIUM IVF AND WOMEN HEALTH LIMITED
  • Address: B1/51, Janak Puri, New Delhi – 110058, India
  • Email: compliance@gaudiumivfcentre.com
  • Telephone: +91-11-4885 8585

Conclusion

The Gaudium IVF IPO presents a rare chance to invest in India’s first listed fertility services company. With strong revenue growth, ambitious plans to open new centres, and a key role in addressing infertility in the healthcare sector, it offers investors exposure to a rapidly growing and specialised market.

The information provided here is for educational purposes only and should not be considered as investment advice. Investors should do their own research or contact their financial advisors before making any investment decisions. Grey Market Premiums (GMPs) are unofficial indicators. Past performance does not guarantee future results.

Related Articles:

1. Shadowfax IPO GMP, Price, Date, Allotment & Subscription Status
2. Yashhtej Industries IPO GMP, Price, Date, Allotment & Subscription Status
3. Bharat Coking Coal IPO GMP, Price, Date, Allotment & Subscription Status
4. Clean Max Enviro Energy IPO GMP, Price, Date, Allotment & Subscription Status
5. Shree Ram Twistex IPO GMP, Price, Date, Allotment & Subscription Status

Frequently Asked Questions

What is the lot size for Yashraj Industries IPO GMP?

Gaudium IVF and Women's Health Limited IPO lot size is 189 shares (minimum application: ₹14,931 at the upper price band of ₹79).

When is the listing date for Gaudium IVF and Women's Health Limited?

Gaudium IVF and Women's Health Limited listing date is February 27, 2026 (on BSE and NSE).

Who is the owner of Gaudium IVF and Women's Health Limited?

Gaudium IVF and Women's Health Limited is founded and led by Dr. Manika Khanna (Founder, Chairperson & Managing Director).

What is the profit of Gaudium IVF and Women's Health Limited?

Gaudium IVF reported a Profit After Tax of ₹19.13 crore for FY25

About the Author
author-img

REPAKA PAVAN ADITYA

Stocks and Mutual Funds Research Analyst
social iconssocial icons

I manifest my zeal in financial quantitative & quantitative research and have been instrumental in creating a robust process for the evaluation and monitoring of mutual funds. I’m responsible for Equity and Mutual Funds Research while creating instrumental mathematical models for portfolio construction after evaluating funds, and I play an integral role in analyzing changes in mutual funds, micro, and macro-economic indicators, and equity market events and trends. My views on asset classes which are integral in creating an investment strategy for any profile. Read more

Clear offers taxation & financial solutions to individuals, businesses, organizations & chartered accountants in India. Clear serves 1.5+ Million happy customers, 20000+ CAs & tax experts & 10000+ businesses across India.

Efiling Income Tax Returns(ITR) is made easy with Clear platform. Just upload your form 16, claim your deductions and get your acknowledgment number online. You can efile income tax return on your income from salary, house property, capital gains, business & profession and income from other sources. Further you can also file TDS returns, generate Form-16, use our Tax Calculator software, claim HRA, check refund status and generate rent receipts for Income Tax Filing.

CAs, experts and businesses can get GST ready with Clear GST software & certification course. Our GST Software helps CAs, tax experts & business to manage returns & invoices in an easy manner. Our Goods & Services Tax course includes tutorial videos, guides and expert assistance to help you in mastering Goods and Services Tax. Clear can also help you in getting your business registered for Goods & Services Tax Law.

Save taxes with Clear by investing in tax saving mutual funds (ELSS) online. Our experts suggest the best funds and you can get high returns by investing directly or through SIP. Download Black by ClearTax App to file returns from your mobile phone.

Office Address - Defmacro Software Private Limited, C 245A, Ground floor, Room No 1, Vikas Puri, West Delhi, New Delhi, Delhi 110018, India

Cleartax is a product by Defmacro Software Pvt. Ltd.

Privacy PolicyTerms of use

ISO

ISO 27001

Data Center

SSL

SSL Certified Site

128-bit encryption